Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Posttranslational control of lipogenesis in the tumor microenvironment
Yahui Zhu, Xingrong Lin, Xiaojun Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 118
The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation
Jef Haerinck, Steven Goossens, Geert Berx
Nature Reviews Genetics (2023) Vol. 24, Iss. 9, pp. 590-609
Closed Access | Times Cited: 71
Lactylated Apolipoprotein C‐II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis
Jian Chen, Deping Zhao, Yupeng Wang, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 21
Nanomaterials: Breaking through the bottleneck of tumor immunotherapy
Yue Kang, Shenglong Li
International Journal of Biological Macromolecules (2023) Vol. 230, pp. 123159-123159
Closed Access | Times Cited: 42
TRIM21‐Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers
Jun Gong, Yuhui Liu, Wenjia Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 29
Open Access | Times Cited: 25
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 13
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 7
ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma
Mingzhi Wu, Xiaojun Zhou, Xinyi Zhou, et al.
Cell Reports (2024) Vol. 43, Iss. 11, pp. 114962-114962
Open Access | Times Cited: 7
Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment
Jun Ouyang, Dong-de Wu, Y. Gan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation
Jijun Shan, Zhiwen Chen, Mo Chen, et al.
Cancer Letters (2025), pp. 217770-217770
Closed Access
Multi-Omics Investigation of Fatty Acid Content Variations in Common Carp (Cyprinus carpio) Muscle: Integrating Genome, Transcriptome, and Lipid Profiling Data
Kaikuo Wang, Qi Wang, Yingjie Chen, et al.
Fishes (2025) Vol. 10, Iss. 5, pp. 234-234
Open Access
Glioblastoma stem cell metabolism and immunity
Joseph Hawly, Micaela G. Murcar, Alejandro Schcolnik‐Cabrera, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3
Recent progress in gene therapy for familial hypercholesterolemia treatment
Yaxin Luo, Yaofeng Hou, Wenwen Zhao, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110641-110641
Open Access | Times Cited: 3
Progress in histology specific treatments in soft tissue sarcoma
Stefano Radaelli, Alessandra Merlini, Misbah Khan, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 845-868
Open Access | Times Cited: 2
GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
Tengling Luo, Junwei Peng, Qijun Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13740-13740
Open Access | Times Cited: 7
FOXN Transcription Factors: Regulation and Significant Role in Cancer
Jiali Song, Longshan Li, Fang Yang, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 9, pp. 1028-1039
Open Access | Times Cited: 3
DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells
Aistė Savukaitytė, Agnė Bartnykaitė, Justina Bekampytė, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4665-4674
Open Access | Times Cited: 1
Roles of posttranslational modifications in lipid metabolism and cancer progression
Tianyu Feng, He Zhang, Yanjie Zhou, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Page 1

Scroll to top